IP Library Granted Patent US 9,309,216
Granted Patent B2
US 9,309,216 · App. 14/398,902 · Granted Apr 12, 2016

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

Inventors: Jayaraman V. Raman (Vadodara, IN); Swaroop K. Vakkalanka (La Chaux-de-Fonds, CH)
Assignee: RHIZEN PHARMACEUTICALS SA
C07D311/36C07D405/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,216
App. No.
14/398,902
Granted
Apr 12, 2016
Kind
B2
Abstract

The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the processes, and to the use of the intermediates in the preparation of pharmaceuticals. In particular, the present invention concerns enantiomerically pure optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives represented by formula (IA) and (IB), processes for preparing the alcohol derivatives and their use in preparing pharmaceuticals.

Claims (76)

1. A process for preparing a compound of formula (IA)

or a salt thereof, the process comprising

(a) reacting a compound of formula (6) with a compound of formula (A)

to obtain a compound of formula (7a)

and

(b) deprotecting the compound formed in step (a) to obtain a compound of formula (IA); and

(c) optionally converting the compound of formula (IA) to a salt thereof,

wherein

each occurrence of R is independently selected from hydrogen, hydroxy, halogen, carboxyl, cyano, nitro, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenylalkyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroarylalkyl, —COOR x , —C(O)R x , —C(S)R x , —C(O)NR x R y , —C(O)ONR x R y , —NR x R y , —NR x CONR x R y , —N(R x ) SOR x , —N(R x )SO 2 R y , —(═N—N(R x )R y ), —NR x C(O)OR y , —NR x C(O)R y —, —NR x C(S)R y —NR x C(S)NR x R y , —SONR x R y , —SO 2 NR x R y , —OR x , —OR x C(O)NR x R y , —OR x C(O)OR x , —OC(O)R x , —OC(O)NR x R y , —R x NR y C(O)R z , —R x OR y , —R x C(O)OR y , —R x C(O)NR x R y , —R x C(O)R y , —R x OC(O)R y , —SR x , —SOR x , —SO 2 R x , and —ONO 2 , wherein each occurrence of R x , R y and R z is independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroarylalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl ring, or substituted or unsubstituted amino, or (i) any two of R x and R y , when bound to a common atom, are joined to form a substituted or unsubstituted, saturated or unsaturated 3-14 membered ring, which may optionally include heteroatoms which may be the same or different and are selected from O, NR z or S, or (ii) any two of R x and R y , when bound to a common atom, are joined to form an oxo (═O), thio (═S) or imino (═NR f ) (wherein R f is hydrogen or substituted or unsubstituted alkyl);

R 1 is substituted or unsubstituted C 1-6 alkyl;

Cy 1 is a monocyclic or bicyclic group selected from substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;

Pg is a protecting group; and

n is an integer selected from 0, 1, 2, 3 or 4.

2. The process of claim 1 , wherein the compound of formula (6) is prepared by a process comprising

(a) converting a compound of formula (1)

wherein Pg is a protecting group, to a compound of formula (2)

(b) converting the compound of formula (2) to a compound of formula (3)

(c) converting the compound of formula (3) to a compound of formula (5)

wherein R, n, Cy 1 and Pg are as defined in claim 1 ; and

(d) deprotecting the compound of formula (5) to obtain a compound of formula (6)

3. The process of claim 1 , wherein the compound of formula (IA) has the formula (IA-I)

the process comprising

(a) converting a compound of formula (1a)

to a compound of formula (2a)

wherein Pg is a protecting group;

(b) converting a compound of formula (2a) to a compound of formula (3a)

(c) converting a compound of formula (3a) to a compound of formula (5a)

(d) deprotecting the compound of formula (5a) to obtain a compound of formula (6a)

(e) reacting the compound of formula (6a) with a compound of formula (A)

to afford a compound of formula (7aa)

(f) deprotecting the compound of formula (7aa) to obtain the compound of formula (IA-I); and

(g) optionally converting the compound of formula (IA-I) to a salt thereof.

4. The process of any claim 1 , wherein the compound of formula (IA) has the formula (IA-II)

the process comprising

(a) converting a compound of formula (1b)

wherein Pg is a protecting group, to a compound of formula (2b)

(b) converting a compound of formula (2b) to a compound of formula (3b)

(c) converting the compound of formula (3b) to a compound of formula (5b)

(d) deprotecting the compound of formula (5b) to obtain a compound of formula (6b)

(e) reacting the compound of formula (6b) with a compound of formula (A)

to afford a compound of formula (7ab)

and

(f) deprotecting the compound of formula (7ab) to obtain the compound of formula (IA-II); and

(g) optionally converting the compound of formula (IA-II) to a salt thereof.

5. A process for preparing a compound of formula (IB)

or a salt thereof, the process comprising

(a) reacting a compound of formula (6) with a compound of formula (B)

to obtain a compound of formula (7b)

(b) deprotecting the compound formed in step (a) to obtain a compound of formula (IB); and

(c) optionally converting the compound of formula (IB) to a salt thereof,

wherein

each occurrence of R is independently selected from hydrogen, hydroxy, halogen, carboxyl, cyano, nitro, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenylalkyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroarylalkyl, —COOR x , —C(O)R x , —C(S)R x , —C(O)NR x R y , —C(O)ONR x R y , —NR x R y , —NR x CONR x R y , —N(R x )SOR x , —N(R x )SO 2 R y , —(═N—N(R x )R y ), —NR x C(O)OR y , —NR x C(O)R y —, —NR x C(S)R y —NR x C(S)NR x R y , —SONR x R y , —SO 2 NR x R y , —OR x , —OR x C(O)NR x R y , —OR x C(O)OR x , —OC(O)R x , —OC(O)NR x R y , —R x NR y C(O)R z , —R x OR y , —R x C(O)OR y , —R x C(O)NR x R y , —R x C(O)R y , —R x OC(O)R y , —SR x , —SOR x , —SO 2 R x , and —ONO 2 , wherein each occurrence of R x , R y and R z is independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroarylalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl ring, or substituted or unsubstituted amino, or (i) any two of R x and R y , when bound to a common atom, are joined to form a substituted or unsubstituted, saturated or unsaturated 3-14 membered ring, which may optionally include heteroatoms which may be the same or different and are selected from O, NR z or S, or (ii) any two of R x and R y , when bound to a common atom, are joined to form an oxo (═O), thio (═S) or imino (═NR f ) (wherein R f is hydrogen or substituted or unsubstituted alkyl);

R 1 is substituted or unsubstituted C 1-6 alkyl;

Cy 1 is a monocyclic or bicyclic group selected from substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;

Pg is a protecting group; and

n is 0, 1, 2, 3 or 4.

6. The process of claim 5 , wherein the compound of formula (6) is prepared by a process comprising

(a) converting a compound of formula (1)

to a compound of formula (2)

wherein Pg is a protecting group;

(b) converting the compound of formula (2) to a compound of formula (3)

(c) converting the compound of formula (3) to a compound of formula (5)

and

(d) deprotecting the compound of formula (5) to obtain a compound of formula (6)

7. The process of claim 5 , wherein the compound of formula (IB) has the formula (IB-I)

the process comprising

(a) reacting the compound of formula (6a) with a compound of formula (B)

to obtain a compound of formula (7ba)

(b) deprotecting the compound of formula (7ba) to obtain the compound of formula (IB-I); and

(c) optionally converting the compound of formula (IB-I) to a salt thereof.

8. A process of claim 5 , wherein the compound of formula (IB) has the formula (IB-II)

and the process comprises the steps of

(a) reacting the compound of formula (6b) with a compound of formula (B)

to obtain a compound of formula (7bb)

(b) deprotecting the compound of formula (7bb) to obtain the compound of formula (IB-II); and

(c) optionally converting the compound of formula (IB-II) to a salt thereof.

Assignments (3)
CHANGE OF ADDRESS Recorded Oct 6, 2021
From: RHIZEN PHARMACEUTICALS AG
To: RHIZEN PHARMACEUTICALS AG
Reel/Frame 057836/0286 →
CHANGE OF ADDRESS Recorded Mar 22, 2021
From: RHIZEN PHARMACEUTICALS SA
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 056775/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2015
From: RAMAN, JAYARAMAN V; VAKKALANKA, SWAROOP K
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 034953/0521 →
Priority Claims (1)
IN 1737/CHE/2012 · May 4, 2012 · national
Continuity (2)
Provisional Application 61671956 · Jul 16, 2012
Related Publication 20150087699A1 · Mar 26, 2015